NCT01995604

Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face

A Single Center, Double Blinded, Placebo Controlled, Randomized, Split Face Study to Evaluate the Efficacy of dHACM (Dehydrated Human Amnion Chorion Membrane) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: MiMedx Group, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy of dHACM (Dehydrated Human Amnion Chorion Membrane) for reducing time to healing when used in post-laser recovery following ActiveFX™ and DeepFx™ fractionated ablative CO2 laser resurfacing of the face.

Conditions

• Scarring

Interventions

Type	Name	Description
OTHER	Application of Sterile 0.9% Saline Solution	Application of Sterile 0.9% Saline Solution to half of face after UltraPulse laser therapy.
OTHER	Application of dHACM	Application of dHACM to half of face after UltraPulse laser therapy.

Timeline

• Start date: 2013-09-01
• Primary completion: 2013-11-01
• Completion: 2013-12-01
• First posted: 2013-11-26
• Last updated: 2014-06-13

Locations

1 site across 1 country: United States